Literature DB >> 11575263

Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease.

J Y Kim, B S Kim, J H Kang.   

Abstract

A 37-year-old Korean woman was admitted at 31 weeks gestation with exertional dyspnea. Three years ago she was diagnosed as having Graves' disease. Thyrotoxicosis-induced dilated cardiomyopathy was diagnosed by echocardiography. During management, a first attack of seizure occurred. Brain MRI and MRA showed occlusion of both internal carotid arteries, which confirmed the diagnosis of Moyamoya disease. Coexistence of dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease is rare and the pathogenic correlation is discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11575263     DOI: 10.1016/s0167-5273(01)00475-2

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.

Authors:  Shigeo Ohba; Toru Nakagawa; Hideki Murakami
Journal:  Neurosurg Rev       Date:  2011-03-19       Impact factor: 3.042

Review 2.  Rapidly progressive fatal bihemispheric infarction secondary to Moyamoya syndrome in association with Graves thyrotoxicosis.

Authors:  S W Hsu; J C Chaloupka; D Fattal
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

3.  Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat.

Authors:  Bo Hyun Kim; Kyoung Im Cho; Seong Man Kim; Nari Kim; Jin Han; Jee Yeon Kim; In Ju Kim
Journal:  Heart Vessels       Date:  2012-11-11       Impact factor: 2.037

Review 4.  Pathophysiology and management of intracranial arterial stenosis around the circle of Willis associated with hyperthyroidism: case reports and literature review.

Authors:  Fumihiro Matano; Yasuo Murai; Koji Adachi; Takayuki Kitamura; Akira Teramoto
Journal:  Neurosurg Rev       Date:  2013-11-19       Impact factor: 3.042

5.  Immune response profiling identifies autoantibodies specific to Moyamoya patients.

Authors:  Tara K Sigdel; Lorelei D Shoemaker; Rong Chen; Li Li; Atul J Butte; Minnie M Sarwal; Gary K Steinberg
Journal:  Orphanet J Rare Dis       Date:  2013-03-21       Impact factor: 4.123

Review 6.  A case of Moyamoya disease in a girl with thyrotoxicosis.

Authors:  Ran Lee; Kihye Sung; Yong Mean Park; Jeong Jin Yu; Young-Cho Koh; Sochung Chung
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.